Global G-Protein Coupled Receptor (GPCR) Targeting Market Growth (Status and Outlook) 2026-2032
Product Code: 2018253
Industry: Pharma & Healthcare
Published: Jun 28,2026
Pages: 124
Delivery Time: 2-3 business days
Global G-Protein Coupled Receptor (GPCR) Targeting Market Growth (Status and Outlook) 2026-2032
Product Code: 2018253
Industry: Pharma & Healthcare
Published: Jun 28,2026
Pages: 124
Delivery Time: 2-3 business days
Select A Format
Single User License
USD3660
Multi Users License
USD5490
Corporate Users License
USD7320
Buy Now
Add To Cart
Or More Options：
PDF Download
Sample Request
Custom Request
Description
The global G-Protein Coupled Receptor (GPCR) Targeting market size is predicted to grow from US$ 1827 million in 2025 to US$ 3344 million in 2032; it is expected to grow at a CAGR of 9.2% from 2026 to 2032.
G protein–coupled receptors (GPCRs) which are also known as seven-transmembrane domain receptors, 7TM receptors, heptahelical receptors, serpentine receptor, and G protein–linked receptors (GPLR), constitute a large protein family of receptors that detect molecules outside the cell and activate internal signal transduction pathways and, ultimately, cellular responses. Coupling with G proteins, they are called seven-transmembrane receptors because they pass through the cell membrane seven times.The average gross profit margin of this product is 55%.
GPCRs regulate metabolism, neurotransmission, immune responses, endocrine functions, and cardiovascular homeostasis, providing broad opportunities across major disease areas. Continued clinical validation of incretin and related receptor pathways in metabolic diseases has elevated strategic interest in GPCR-targeted therapies and encouraged development beyond single receptors toward dual- and multi-receptor modulation. Advances in cryo-electron microscopy, crystallography, artificial intelligence-assisted molecular design, and molecular dynamics simulation are converting previously inaccessible receptor conformations into actionable information for drug discovery. Emerging approaches such as biased agonism, allosteric modulation, and orally available non-peptide agonists may improve selectivity, convenience, and therapeutic windows while maintaining pharmacological efficacy. In addition, orphan GPCRs and receptors with tissue-specific expression remain underexploited, creating differentiated target opportunities for innovative biotechnology and pharmaceutical companies.
GPCR signaling networks are highly dynamic and vary across tissues, cell types, and physiological conditions. A single receptor may activate different G-protein subtypes and β-arrestin pathways, making in vitro activity difficult to translate directly into human efficacy and safety. Structural similarity among receptor subtypes can also cause off-target effects, particularly in neurological, cardiovascular, and endocrine applications, where limited selectivity may produce dose-limiting adverse events. Some GPCRs lack well-defined endogenous ligands, validated disease biomarkers, or predictive animal models, increasing the uncertainty of target validation and clinical translation. Peptide and antibody modalities may face challenges related to administration, tissue penetration, and manufacturing complexity, while oral small molecules must balance potency, selectivity, pharmacokinetics, and long-term safety. Dense patent landscapes, increasing competition around validated targets, and complex clinical endpoints further raise development and commercialization risks.
Pharmaceutical and biotechnology companies are moving beyond conventional single-target agonists and antagonists toward precise control of receptor signaling and more highly stratified patient populations. Metabolic disease programs will continue to emphasize oral delivery, multi-receptor mechanisms, and therapies capable of addressing both weight management and related complications. Programs in neurological, psychiatric, pain, and immune disorders increasingly prioritize brain exposure, receptor-subtype selectivity, and reduced tolerance or adverse effects. Large pharmaceutical companies are showing greater demand for partnerships with technology providers that possess validated discovery platforms, structural biology capabilities, and differentiated target assets, supporting licensing, co-development, and platform-oriented transactions. Screening requirements are also expanding from basic ligand-binding assays toward multi-pathway functional testing, receptor internalization, biased signaling, and cell-phenotype analysis. As precision medicine advances, receptor expression profiles, genetic variants, and pharmacodynamic biomarkers will become more deeply integrated into clinical development.
LPI (LP Information)' newest research report, the “G-Protein Coupled Receptor (GPCR) Targeting Industry Forecast” looks at past sales and reviews total world G-Protein Coupled Receptor (GPCR) Targeting sales in 2025, providing a comprehensive analysis by region and market sector of projected G-Protein Coupled Receptor (GPCR) Targeting sales for 2026 through 2032. With G-Protein Coupled Receptor (GPCR) Targeting sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world G-Protein Coupled Receptor (GPCR) Targeting industry.
This Insight Report provides a comprehensive analysis of the global G-Protein Coupled Receptor (GPCR) Targeting landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on G-Protein Coupled Receptor (GPCR) Targeting portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global G-Protein Coupled Receptor (GPCR) Targeting market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for G-Protein Coupled Receptor (GPCR) Targeting and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global G-Protein Coupled Receptor (GPCR) Targeting.
This report presents a comprehensive overview, market shares, and growth opportunities of G-Protein Coupled Receptor (GPCR) Targeting market by product type, application, key players and key regions and countries.
Segmentation by Type:
GPCR Consumables
GPCR Equipment
Segmentation by Research Application:
Ligand Binding Assay
cAMP Assay
Calcium Flux Assay
Beta-arrestin Assay
Other
Segmentation by Customer Segment:
Pharmaceutical R&D
CRO Laboratory
Academic Research
Biotech Company
Other
Segmentation by Application:
Oncology
Cardiovascular System
Central Nervous System
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
PerkinElmer
Eurofins DiscoverX
Charles River Laboratories
Cisbio Bioassays
Promega
Abcam
Selleck Chemicals
WuXi AppTec
GenScript
Shanghai Medicilon
Merck
BD Biosciences
Molecular Devices
Qiagen
Corning
Discoverx
Table Of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global G-Protein Coupled Receptor (GPCR) Targeting Market Size (2021-2032)
2.1.2 G-Protein Coupled Receptor (GPCR) Targeting Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for G-Protein Coupled Receptor (GPCR) Targeting by Country/Region (2021, 2025 & 2032)
2.2 G-Protein Coupled Receptor (GPCR) Targeting Segment by Type
2.2.1 GPCR Consumables
2.2.2 GPCR Equipment
2.2.3 G-Protein Coupled Receptor (GPCR) Targeting Market Size by Type
2.2.3.1 G-Protein Coupled Receptor (GPCR) Targeting Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global G-Protein Coupled Receptor (GPCR) Targeting Market Size Market Share by Type (2021-2026)
2.3 G-Protein Coupled Receptor (GPCR) Targeting Segment by Research Application
2.3.1 Ligand Binding Assay
2.3.2 cAMP Assay
2.3.3 Calcium Flux Assay
2.3.4 Beta-arrestin Assay
2.3.5 Other
2.3.6 G-Protein Coupled Receptor (GPCR) Targeting Market Size by Research Application
2.3.6.1 G-Protein Coupled Receptor (GPCR) Targeting Market Size CAGR by Research Application (2021 VS 2025 VS 2032)
2.3.6.2 Global G-Protein Coupled Receptor (GPCR) Targeting Market Size Market Share by Research Application (2021-2026)
2.4 G-Protein Coupled Receptor (GPCR) Targeting Segment by Customer Segment
2.4.1 Pharmaceutical R&D
2.4.2 CRO Laboratory
2.4.3 Academic Research
2.4.4 Biotech Company
2.4.5 Other
2.4.6 G-Protein Coupled Receptor (GPCR) Targeting Market Size by Customer Segment
2.4.6.1 G-Protein Coupled Receptor (GPCR) Targeting Market Size CAGR by Customer Segment (2021 VS 2025 VS 2032)
2.4.6.2 Global G-Protein Coupled Receptor (GPCR) Targeting Market Size Market Share by Customer Segment (2021-2026)
2.5 G-Protein Coupled Receptor (GPCR) Targeting Segment by Application
2.5.1 Oncology
2.5.2 Cardiovascular System
2.5.3 Central Nervous System
2.5.4 Other
2.5.5 G-Protein Coupled Receptor (GPCR) Targeting Market Size by Application
2.5.5.1 G-Protein Coupled Receptor (GPCR) Targeting Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.5.2 Global G-Protein Coupled Receptor (GPCR) Targeting Market Size Market Share by Application (2021-2026)
3 G-Protein Coupled Receptor (GPCR) Targeting Market Size by Player
3.1 G-Protein Coupled Receptor (GPCR) Targeting Market Size Market Share by Player
3.1.1 Global G-Protein Coupled Receptor (GPCR) Targeting Revenue by Player (2021-2026)
3.1.2 Global G-Protein Coupled Receptor (GPCR) Targeting Revenue Market Share by Player (2021-2026)
3.2 Global G-Protein Coupled Receptor (GPCR) Targeting Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 G-Protein Coupled Receptor (GPCR) Targeting by Region
4.1 G-Protein Coupled Receptor (GPCR) Targeting Market Size by Region (2021-2026)
4.2 Global G-Protein Coupled Receptor (GPCR) Targeting Annual Revenue by Country/Region (2021-2026)
4.3 Americas G-Protein Coupled Receptor (GPCR) Targeting Market Size Growth (2021-2026)
4.4 APAC G-Protein Coupled Receptor (GPCR) Targeting Market Size Growth (2021-2026)
4.5 Europe G-Protein Coupled Receptor (GPCR) Targeting Market Size Growth (2021-2026)
4.6 Middle East & Africa G-Protein Coupled Receptor (GPCR) Targeting Market Size Growth (2021-2026)
5 Americas
5.1 Americas G-Protein Coupled Receptor (GPCR) Targeting Market Size by Country (2021-2026)
5.2 Americas G-Protein Coupled Receptor (GPCR) Targeting Market Size by Type (2021-2026)
5.3 Americas G-Protein Coupled Receptor (GPCR) Targeting Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC G-Protein Coupled Receptor (GPCR) Targeting Market Size by Region (2021-2026)
6.2 APAC G-Protein Coupled Receptor (GPCR) Targeting Market Size by Type (2021-2026)
6.3 APAC G-Protein Coupled Receptor (GPCR) Targeting Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe G-Protein Coupled Receptor (GPCR) Targeting Market Size by Country (2021-2026)
7.2 Europe G-Protein Coupled Receptor (GPCR) Targeting Market Size by Type (2021-2026)
7.3 Europe G-Protein Coupled Receptor (GPCR) Targeting Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa G-Protein Coupled Receptor (GPCR) Targeting by Region (2021-2026)
8.2 Middle East & Africa G-Protein Coupled Receptor (GPCR) Targeting Market Size by Type (2021-2026)
8.3 Middle East & Africa G-Protein Coupled Receptor (GPCR) Targeting Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global G-Protein Coupled Receptor (GPCR) Targeting Market Forecast
10.1 Global G-Protein Coupled Receptor (GPCR) Targeting Forecast by Region (2027-2032)
10.1.1 Global G-Protein Coupled Receptor (GPCR) Targeting Forecast by Region (2027-2032)
10.1.2 Americas G-Protein Coupled Receptor (GPCR) Targeting Forecast
10.1.3 APAC G-Protein Coupled Receptor (GPCR) Targeting Forecast
10.1.4 Europe G-Protein Coupled Receptor (GPCR) Targeting Forecast
10.1.5 Middle East & Africa G-Protein Coupled Receptor (GPCR) Targeting Forecast
10.2 Americas G-Protein Coupled Receptor (GPCR) Targeting Forecast by Country (2027-2032)
10.2.1 United States Market G-Protein Coupled Receptor (GPCR) Targeting Forecast
10.2.2 Canada Market G-Protein Coupled Receptor (GPCR) Targeting Forecast
10.2.3 Mexico Market G-Protein Coupled Receptor (GPCR) Targeting Forecast
10.2.4 Brazil Market G-Protein Coupled Receptor (GPCR) Targeting Forecast
10.3 APAC G-Protein Coupled Receptor (GPCR) Targeting Forecast by Region (2027-2032)
10.3.1 China G-Protein Coupled Receptor (GPCR) Targeting Market Forecast
10.3.2 Japan Market G-Protein Coupled Receptor (GPCR) Targeting Forecast
10.3.3 Korea Market G-Protein Coupled Receptor (GPCR) Targeting Forecast
10.3.4 Southeast Asia Market G-Protein Coupled Receptor (GPCR) Targeting Forecast
10.3.5 India Market G-Protein Coupled Receptor (GPCR) Targeting Forecast
10.3.6 Australia Market G-Protein Coupled Receptor (GPCR) Targeting Forecast
10.4 Europe G-Protein Coupled Receptor (GPCR) Targeting Forecast by Country (2027-2032)
10.4.1 Germany Market G-Protein Coupled Receptor (GPCR) Targeting Forecast
10.4.2 France Market G-Protein Coupled Receptor (GPCR) Targeting Forecast
10.4.3 UK Market G-Protein Coupled Receptor (GPCR) Targeting Forecast
10.4.4 Italy Market G-Protein Coupled Receptor (GPCR) Targeting Forecast
10.4.5 Russia Market G-Protein Coupled Receptor (GPCR) Targeting Forecast
10.5 Middle East & Africa G-Protein Coupled Receptor (GPCR) Targeting Forecast by Region (2027-2032)
10.5.1 Egypt Market G-Protein Coupled Receptor (GPCR) Targeting Forecast
10.5.2 South Africa Market G-Protein Coupled Receptor (GPCR) Targeting Forecast
10.5.3 Israel Market G-Protein Coupled Receptor (GPCR) Targeting Forecast
10.5.4 Turkey Market G-Protein Coupled Receptor (GPCR) Targeting Forecast
10.6 Global G-Protein Coupled Receptor (GPCR) Targeting Forecast by Type (2027-2032)
10.7 Global G-Protein Coupled Receptor (GPCR) Targeting Forecast by Application (2027-2032)
10.7.1 GCC Countries Market G-Protein Coupled Receptor (GPCR) Targeting Forecast
11 Key Players Analysis
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific G-Protein Coupled Receptor (GPCR) Targeting Product Offered
11.1.3 Thermo Fisher Scientific G-Protein Coupled Receptor (GPCR) Targeting Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 PerkinElmer
11.2.1 PerkinElmer Company Information
11.2.2 PerkinElmer G-Protein Coupled Receptor (GPCR) Targeting Product Offered
11.2.3 PerkinElmer G-Protein Coupled Receptor (GPCR) Targeting Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 PerkinElmer Main Business Overview
11.2.5 PerkinElmer Latest Developments
11.3 Eurofins DiscoverX
11.3.1 Eurofins DiscoverX Company Information
11.3.2 Eurofins DiscoverX G-Protein Coupled Receptor (GPCR) Targeting Product Offered
11.3.3 Eurofins DiscoverX G-Protein Coupled Receptor (GPCR) Targeting Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Eurofins DiscoverX Main Business Overview
11.3.5 Eurofins DiscoverX Latest Developments
11.4 Charles River Laboratories
11.4.1 Charles River Laboratories Company Information
11.4.2 Charles River Laboratories G-Protein Coupled Receptor (GPCR) Targeting Product Offered
11.4.3 Charles River Laboratories G-Protein Coupled Receptor (GPCR) Targeting Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Charles River Laboratories Main Business Overview
11.4.5 Charles River Laboratories Latest Developments
11.5 Cisbio Bioassays
11.5.1 Cisbio Bioassays Company Information
11.5.2 Cisbio Bioassays G-Protein Coupled Receptor (GPCR) Targeting Product Offered
11.5.3 Cisbio Bioassays G-Protein Coupled Receptor (GPCR) Targeting Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Cisbio Bioassays Main Business Overview
11.5.5 Cisbio Bioassays Latest Developments
11.6 Promega
11.6.1 Promega Company Information
11.6.2 Promega G-Protein Coupled Receptor (GPCR) Targeting Product Offered
11.6.3 Promega G-Protein Coupled Receptor (GPCR) Targeting Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Promega Main Business Overview
11.6.5 Promega Latest Developments
11.7 Abcam
11.7.1 Abcam Company Information
11.7.2 Abcam G-Protein Coupled Receptor (GPCR) Targeting Product Offered
11.7.3 Abcam G-Protein Coupled Receptor (GPCR) Targeting Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Abcam Main Business Overview
11.7.5 Abcam Latest Developments
11.8 Selleck Chemicals
11.8.1 Selleck Chemicals Company Information
11.8.2 Selleck Chemicals G-Protein Coupled Receptor (GPCR) Targeting Product Offered
11.8.3 Selleck Chemicals G-Protein Coupled Receptor (GPCR) Targeting Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Selleck Chemicals Main Business Overview
11.8.5 Selleck Chemicals Latest Developments
11.9 WuXi AppTec
11.9.1 WuXi AppTec Company Information
11.9.2 WuXi AppTec G-Protein Coupled Receptor (GPCR) Targeting Product Offered
11.9.3 WuXi AppTec G-Protein Coupled Receptor (GPCR) Targeting Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 WuXi AppTec Main Business Overview
11.9.5 WuXi AppTec Latest Developments
11.10 GenScript
11.10.1 GenScript Company Information
11.10.2 GenScript G-Protein Coupled Receptor (GPCR) Targeting Product Offered
11.10.3 GenScript G-Protein Coupled Receptor (GPCR) Targeting Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 GenScript Main Business Overview
11.10.5 GenScript Latest Developments
11.11 Shanghai Medicilon
11.11.1 Shanghai Medicilon Company Information
11.11.2 Shanghai Medicilon G-Protein Coupled Receptor (GPCR) Targeting Product Offered
11.11.3 Shanghai Medicilon G-Protein Coupled Receptor (GPCR) Targeting Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Shanghai Medicilon Main Business Overview
11.11.5 Shanghai Medicilon Latest Developments
11.12 Merck
11.12.1 Merck Company Information
11.12.2 Merck G-Protein Coupled Receptor (GPCR) Targeting Product Offered
11.12.3 Merck G-Protein Coupled Receptor (GPCR) Targeting Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Merck Main Business Overview
11.12.5 Merck Latest Developments
11.13 BD Biosciences
11.13.1 BD Biosciences Company Information
11.13.2 BD Biosciences G-Protein Coupled Receptor (GPCR) Targeting Product Offered
11.13.3 BD Biosciences G-Protein Coupled Receptor (GPCR) Targeting Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 BD Biosciences Main Business Overview
11.13.5 BD Biosciences Latest Developments
11.14 Molecular Devices
11.14.1 Molecular Devices Company Information
11.14.2 Molecular Devices G-Protein Coupled Receptor (GPCR) Targeting Product Offered
11.14.3 Molecular Devices G-Protein Coupled Receptor (GPCR) Targeting Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Molecular Devices Main Business Overview
11.14.5 Molecular Devices Latest Developments
11.15 Qiagen
11.15.1 Qiagen Company Information
11.15.2 Qiagen G-Protein Coupled Receptor (GPCR) Targeting Product Offered
11.15.3 Qiagen G-Protein Coupled Receptor (GPCR) Targeting Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Qiagen Main Business Overview
11.15.5 Qiagen Latest Developments
11.16 Corning
11.16.1 Corning Company Information
11.16.2 Corning G-Protein Coupled Receptor (GPCR) Targeting Product Offered
11.16.3 Corning G-Protein Coupled Receptor (GPCR) Targeting Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Corning Main Business Overview
11.16.5 Corning Latest Developments
11.17 Discoverx
11.17.1 Discoverx Company Information
11.17.2 Discoverx G-Protein Coupled Receptor (GPCR) Targeting Product Offered
11.17.3 Discoverx G-Protein Coupled Receptor (GPCR) Targeting Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Discoverx Main Business Overview
11.17.5 Discoverx Latest Developments
12 Research Findings and Conclusion
List Of Tables
List of Tables Table 1. G-Protein Coupled Receptor (GPCR) Targeting Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions) Table 2. G-Protein Coupled Receptor (GPCR) Targeting Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions) Table 3. Major Players of GPCR Consumables Table 4. Major Players of GPCR Equipment Table 5. G-Protein Coupled Receptor (GPCR) Targeting Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions) Table 6. Global G-Protein Coupled Receptor (GPCR) Targeting Market Size by Type (2021-2026) & ($ millions) Table 7. Global G-Protein Coupled Receptor (GPCR) Targeting Market Size Market Share by Type (2021-2026) Table 8. Major Players of Ligand Binding Assay Table 9. Major Players of cAMP Assay Table 10. Major Players of Calcium Flux Assay Table 11. Major Players of Beta-arrestin Assay Table 12. Major Players of Other Table 13. G-Protein Coupled Receptor (GPCR) Targeting Market Size CAGR by Research Application (2021 VS 2025 VS 2032) & ($ millions) Table 14. Global G-Protein Coupled Receptor (GPCR) Targeting Market Size by Research Application (2021-2026) & ($ millions) Table 15. Global G-Protein Coupled Receptor (GPCR) Targeting Market Size Market Share by Research Application (2021-2026) Table 16. Major Players of Pharmaceutical R&D Table 17. Major Players of CRO Laboratory Table 18. Major Players of Academic Research Table 19. Major Players of Biotech Company Table 20. Major Players of Other Table 21. G-Protein Coupled Receptor (GPCR) Targeting Market Size CAGR by Customer Segment (2021 VS 2025 VS 2032) & ($ millions) Table 22. Global G-Protein Coupled Receptor (GPCR) Targeting Market Size by Customer Segment (2021-2026) & ($ millions) Table 23. Global G-Protein Coupled Receptor (GPCR) Targeting Market Size Market Share by Customer Segment (2021-2026) Table 24. G-Protein Coupled Receptor (GPCR) Targeting Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions) Table 25. Global G-Protein Coupled Receptor (GPCR) Targeting Market Size by Application (2021-2026) & ($ millions) Table 26. Global G-Protein Coupled Receptor (GPCR) Targeting Market Size Market Share by Application (2021-2026) Table 27. Global G-Protein Coupled Receptor (GPCR) Targeting Revenue by Player (2021-2026) & ($ millions) Table 28. Global G-Protein Coupled Receptor (GPCR) Targeting Revenue Market Share by Player (2021-2026) Table 29. G-Protein Coupled Receptor (GPCR) Targeting Key Players Head office and Products Offered Table 30. G-Protein Coupled Receptor (GPCR) Targeting Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) Table 31. New Products and Potential Entrants Table 32. Mergers & Acquisitions, Expansion Table 33. Global G-Protein Coupled Receptor (GPCR) Targeting Market Size by Region (2021-2026) & ($ millions) Table 34. Global G-Protein Coupled Receptor (GPCR) Targeting Market Size Market Share by Region (2021-2026) Table 35. Global G-Protein Coupled Receptor (GPCR) Targeting Revenue by Country/Region (2021-2026) & ($ millions) Table 36. Global G-Protein Coupled Receptor (GPCR) Targeting Revenue Market Share by Country/Region (2021-2026) Table 37. Americas G-Protein Coupled Receptor (GPCR) Targeting Market Size by Country (2021-2026) & ($ millions) Table 38. Americas G-Protein Coupled Receptor (GPCR) Targeting Market Size Market Share by Country (2021-2026) Table 39. Americas G-Protein Coupled Receptor (GPCR) Targeting Market Size by Type (2021-2026) & ($ millions) Table 40. Americas G-Protein Coupled Receptor (GPCR) Targeting Market Size Market Share by Type (2021-2026) Table 41. Americas G-Protein Coupled Receptor (GPCR) Targeting Market Size by Application (2021-2026) & ($ millions) Table 42. Americas G-Protein Coupled Receptor (GPCR) Targeting Market Size Market Share by Application (2021-2026) Table 43. APAC G-Protein Coupled Receptor (GPCR) Targeting Market Size by Region (2021-2026) & ($ millions) Table 44. APAC G-Protein Coupled Receptor (GPCR) Targeting Market Size Market Share by Region (2021-2026) Table 45. APAC G-Protein Coupled Receptor (GPCR) Targeting Market Size by Type (2021-2026) & ($ millions) Table 46. APAC G-Protein Coupled Receptor (GPCR) Targeting Market Size by Application (2021-2026) & ($ millions) Table 47. Europe G-Protein Coupled Receptor (GPCR) Targeting Market Size by Country (2021-2026) & ($ millions) Table 48. Europe G-Protein Coupled Receptor (GPCR) Targeting Market Size Market Share by Country (2021-2026) Table 49. Europe G-Protein Coupled Receptor (GPCR) Targeting Market Size by Type (2021-2026) & ($ millions) Table 50. Europe G-Protein Coupled Receptor (GPCR) Targeting Market Size by Application (2021-2026) & ($ millions) Table 51. Middle East & Africa G-Protein Coupled Receptor (GPCR) Targeting Market Size by Region (2021-2026) & ($ millions) Table 52. Middle East & Africa G-Protein Coupled Receptor (GPCR) Targeting Market Size by Type (2021-2026) & ($ millions) Table 53. Middle East & Africa G-Protein Coupled Receptor (GPCR) Targeting Market Size by Application (2021-2026) & ($ millions) Table 54. Key Market Drivers & Growth Opportunities of G-Protein Coupled Receptor (GPCR) Targeting Table 55. Key Market Challenges & Risks of G-Protein Coupled Receptor (GPCR) Targeting Table 56. Key Industry Trends of G-Protein Coupled Receptor (GPCR) Targeting Table 57. Global G-Protein Coupled Receptor (GPCR) Targeting Market Size Forecast by Region (2027-2032) & ($ millions) Table 58. Global G-Protein Coupled Receptor (GPCR) Targeting Market Size Market Share Forecast by Region (2027-2032) Table 59. Global G-Protein Coupled Receptor (GPCR) Targeting Market Size Forecast by Type (2027-2032) & ($ millions) Table 60. Global G-Protein Coupled Receptor (GPCR) Targeting Market Size Forecast by Application (2027-2032) & ($ millions) Table 61. Thermo Fisher Scientific Details, Company Type, G-Protein Coupled Receptor (GPCR) Targeting Area Served and Its Competitors Table 62. Thermo Fisher Scientific G-Protein Coupled Receptor (GPCR) Targeting Product Offered Table 63. Thermo Fisher Scientific G-Protein Coupled Receptor (GPCR) Targeting Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 64. Thermo Fisher Scientific Main Business Table 65. Thermo Fisher Scientific Latest Developments Table 66. PerkinElmer Details, Company Type, G-Protein Coupled Receptor (GPCR) Targeting Area Served and Its Competitors Table 67. PerkinElmer G-Protein Coupled Receptor (GPCR) Targeting Product Offered Table 68. PerkinElmer G-Protein Coupled Receptor (GPCR) Targeting Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 69. PerkinElmer Main Business Table 70. PerkinElmer Latest Developments Table 71. Eurofins DiscoverX Details, Company Type, G-Protein Coupled Receptor (GPCR) Targeting Area Served and Its Competitors Table 72. Eurofins DiscoverX G-Protein Coupled Receptor (GPCR) Targeting Product Offered Table 73. Eurofins DiscoverX G-Protein Coupled Receptor (GPCR) Targeting Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 74. Eurofins DiscoverX Main Business Table 75. Eurofins DiscoverX Latest Developments Table 76. Charles River Laboratories Details, Company Type, G-Protein Coupled Receptor (GPCR) Targeting Area Served and Its Competitors Table 77. Charles River Laboratories G-Protein Coupled Receptor (GPCR) Targeting Product Offered Table 78. Charles River Laboratories G-Protein Coupled Receptor (GPCR) Targeting Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 79. Charles River Laboratories Main Business Table 80. Charles River Laboratories Latest Developments Table 81. Cisbio Bioassays Details, Company Type, G-Protein Coupled Receptor (GPCR) Targeting Area Served and Its Competitors Table 82. Cisbio Bioassays G-Protein Coupled Receptor (GPCR) Targeting Product Offered Table 83. Cisbio Bioassays G-Protein Coupled Receptor (GPCR) Targeting Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 84. Cisbio Bioassays Main Business Table 85. Cisbio Bioassays Latest Developments Table 86. Promega Details, Company Type, G-Protein Coupled Receptor (GPCR) Targeting Area Served and Its Competitors Table 87. Promega G-Protein Coupled Receptor (GPCR) Targeting Product Offered Table 88. Promega G-Protein Coupled Receptor (GPCR) Targeting Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 89. Promega Main Business Table 90. Promega Latest Developments Table 91. Abcam Details, Company Type, G-Protein Coupled Receptor (GPCR) Targeting Area Served and Its Competitors Table 92. Abcam G-Protein Coupled Receptor (GPCR) Targeting Product Offered Table 93. Abcam G-Protein Coupled Receptor (GPCR) Targeting Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 94. Abcam Main Business Table 95. Abcam Latest Developments Table 96. Selleck Chemicals Details, Company Type, G-Protein Coupled Receptor (GPCR) Targeting Area Served and Its Competitors Table 97. Selleck Chemicals G-Protein Coupled Receptor (GPCR) Targeting Product Offered Table 98. Selleck Chemicals G-Protein Coupled Receptor (GPCR) Targeting Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 99. Selleck Chemicals Main Business Table 100. Selleck Chemicals Latest Developments Table 101. WuXi AppTec Details, Company Type, G-Protein Coupled Receptor (GPCR) Targeting Area Served and Its Competitors Table 102. WuXi AppTec G-Protein Coupled Receptor (GPCR) Targeting Product Offered Table 103. WuXi AppTec G-Protein Coupled Receptor (GPCR) Targeting Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 104. WuXi AppTec Main Business Table 105. WuXi AppTec Latest Developments Table 106. GenScript Details, Company Type, G-Protein Coupled Receptor (GPCR) Targeting Area Served and Its Competitors Table 107. GenScript G-Protein Coupled Receptor (GPCR) Targeting Product Offered Table 108. GenScript G-Protein Coupled Receptor (GPCR) Targeting Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 109. GenScript Main Business Table 110. GenScript Latest Developments Table 111. Shanghai Medicilon Details, Company Type, G-Protein Coupled Receptor (GPCR) Targeting Area Served and Its Competitors Table 112. Shanghai Medicilon G-Protein Coupled Receptor (GPCR) Targeting Product Offered Table 113. Shanghai Medicilon G-Protein Coupled Receptor (GPCR) Targeting Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 114. Shanghai Medicilon Main Business Table 115. Shanghai Medicilon Latest Developments Table 116. Merck Details, Company Type, G-Protein Coupled Receptor (GPCR) Targeting Area Served and Its Competitors Table 117. Merck G-Protein Coupled Receptor (GPCR) Targeting Product Offered Table 118. Merck G-Protein Coupled Receptor (GPCR) Targeting Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 119. Merck Main Business Table 120. Merck Latest Developments Table 121. BD Biosciences Details, Company Type, G-Protein Coupled Receptor (GPCR) Targeting Area Served and Its Competitors Table 122. BD Biosciences G-Protein Coupled Receptor (GPCR) Targeting Product Offered Table 123. BD Biosciences G-Protein Coupled Receptor (GPCR) Targeting Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 124. BD Biosciences Main Business Table 125. BD Biosciences Latest Developments Table 126. Molecular Devices Details, Company Type, G-Protein Coupled Receptor (GPCR) Targeting Area Served and Its Competitors Table 127. Molecular Devices G-Protein Coupled Receptor (GPCR) Targeting Product Offered Table 128. Molecular Devices G-Protein Coupled Receptor (GPCR) Targeting Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 129. Molecular Devices Main Business Table 130. Molecular Devices Latest Developments Table 131. Qiagen Details, Company Type, G-Protein Coupled Receptor (GPCR) Targeting Area Served and Its Competitors Table 132. Qiagen G-Protein Coupled Receptor (GPCR) Targeting Product Offered Table 133. Qiagen G-Protein Coupled Receptor (GPCR) Targeting Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 134. Qiagen Main Business Table 135. Qiagen Latest Developments Table 136. Corning Details, Company Type, G-Protein Coupled Receptor (GPCR) Targeting Area Served and Its Competitors Table 137. Corning G-Protein Coupled Receptor (GPCR) Targeting Product Offered Table 138. Corning G-Protein Coupled Receptor (GPCR) Targeting Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 139. Corning Main Business Table 140. Corning Latest Developments Table 141. Discoverx Details, Company Type, G-Protein Coupled Receptor (GPCR) Targeting Area Served and Its Competitors Table 142. Discoverx G-Protein Coupled Receptor (GPCR) Targeting Product Offered Table 143. Discoverx G-Protein Coupled Receptor (GPCR) Targeting Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 144. Discoverx Main Business Table 145. Discoverx Latest Developments List of Figures Figure 1. G-Protein Coupled Receptor (GPCR) Targeting Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global G-Protein Coupled Receptor (GPCR) Targeting Market Size Growth Rate (2021-2032) ($ millions) Figure 6. G-Protein Coupled Receptor (GPCR) Targeting Sales by Geographic Region (2021, 2025 & 2032) & ($ millions) Figure 7. G-Protein Coupled Receptor (GPCR) Targeting Sales Market Share by Country/Region (2025) Figure 8. G-Protein Coupled Receptor (GPCR) Targeting Sales Market Share by Country/Region (2021, 2025 & 2032) Figure 9. Global G-Protein Coupled Receptor (GPCR) Targeting Market Size Market Share by Type in 2025 Figure 10. Global G-Protein Coupled Receptor (GPCR) Targeting Market Size Market Share by Research Application in 2025 Figure 11. Global G-Protein Coupled Receptor (GPCR) Targeting Market Size Market Share by Customer Segment in 2025 Figure 12. G-Protein Coupled Receptor (GPCR) Targeting in Oncology Figure 13. Global G-Protein Coupled Receptor (GPCR) Targeting Market: Oncology (2021-2026) & ($ millions) Figure 14. G-Protein Coupled Receptor (GPCR) Targeting in Cardiovascular System Figure 15. Global G-Protein Coupled Receptor (GPCR) Targeting Market: Cardiovascular System (2021-2026) & ($ millions) Figure 16. G-Protein Coupled Receptor (GPCR) Targeting in Central Nervous System Figure 17. Global G-Protein Coupled Receptor (GPCR) Targeting Market: Central Nervous System (2021-2026) & ($ millions) Figure 18. G-Protein Coupled Receptor (GPCR) Targeting in Other Figure 19. Global G-Protein Coupled Receptor (GPCR) Targeting Market: Other (2021-2026) & ($ millions) Figure 20. Global G-Protein Coupled Receptor (GPCR) Targeting Market Size Market Share by Application in 2025 Figure 21. Global G-Protein Coupled Receptor (GPCR) Targeting Revenue Market Share by Player in 2025 Figure 22. Global G-Protein Coupled Receptor (GPCR) Targeting Market Size Market Share by Region (2021-2026) Figure 23. Americas G-Protein Coupled Receptor (GPCR) Targeting Market Size 2021-2026 ($ millions) Figure 24. APAC G-Protein Coupled Receptor (GPCR) Targeting Market Size 2021-2026 ($ millions) Figure 25. Europe G-Protein Coupled Receptor (GPCR) Targeting Market Size 2021-2026 ($ millions) Figure 26. Middle East & Africa G-Protein Coupled Receptor (GPCR) Targeting Market Size 2021-2026 ($ millions) Figure 27. Americas G-Protein Coupled Receptor (GPCR) Targeting Value Market Share by Country in 2025 Figure 28. United States G-Protein Coupled Receptor (GPCR) Targeting Market Size Growth 2021-2026 ($ millions) Figure 29. Canada G-Protein Coupled Receptor (GPCR) Targeting Market Size Growth 2021-2026 ($ millions) Figure 30. Mexico G-Protein Coupled Receptor (GPCR) Targeting Market Size Growth 2021-2026 ($ millions) Figure 31. Brazil G-Protein Coupled Receptor (GPCR) Targeting Market Size Growth 2021-2026 ($ millions) Figure 32. APAC G-Protein Coupled Receptor (GPCR) Targeting Market Size Market Share by Region in 2025 Figure 33. APAC G-Protein Coupled Receptor (GPCR) Targeting Market Size Market Share by Type (2021-2026) Figure 34. APAC G-Protein Coupled Receptor (GPCR) Targeting Market Size Market Share by Application (2021-2026) Figure 35. China G-Protein Coupled Receptor (GPCR) Targeting Market Size Growth 2021-2026 ($ millions) Figure 36. Japan G-Protein Coupled Receptor (GPCR) Targeting Market Size Growth 2021-2026 ($ millions) Figure 37. South Korea G-Protein Coupled Receptor (GPCR) Targeting Market Size Growth 2021-2026 ($ millions) Figure 38. Southeast Asia G-Protein Coupled Receptor (GPCR) Targeting Market Size Growth 2021-2026 ($ millions) Figure 39. India G-Protein Coupled Receptor (GPCR) Targeting Market Size Growth 2021-2026 ($ millions) Figure 40. Australia G-Protein Coupled Receptor (GPCR) Targeting Market Size Growth 2021-2026 ($ millions) Figure 41. Europe G-Protein Coupled Receptor (GPCR) Targeting Market Size Market Share by Country in 2025 Figure 42. Europe G-Protein Coupled Receptor (GPCR) Targeting Market Size Market Share by Type (2021-2026) Figure 43. Europe G-Protein Coupled Receptor (GPCR) Targeting Market Size Market Share by Application (2021-2026) Figure 44. Germany G-Protein Coupled Receptor (GPCR) Targeting Market Size Growth 2021-2026 ($ millions) Figure 45. France G-Protein Coupled Receptor (GPCR) Targeting Market Size Growth 2021-2026 ($ millions) Figure 46. UK G-Protein Coupled Receptor (GPCR) Targeting Market Size Growth 2021-2026 ($ millions) Figure 47. Italy G-Protein Coupled Receptor (GPCR) Targeting Market Size Growth 2021-2026 ($ millions) Figure 48. Russia G-Protein Coupled Receptor (GPCR) Targeting Market Size Growth 2021-2026 ($ millions) Figure 49. Middle East & Africa G-Protein Coupled Receptor (GPCR) Targeting Market Size Market Share by Region (2021-2026) Figure 50. Middle East & Africa G-Protein Coupled Receptor (GPCR) Targeting Market Size Market Share by Type (2021-2026) Figure 51. Middle East & Africa G-Protein Coupled Receptor (GPCR) Targeting Market Size Market Share by Application (2021-2026) Figure 52. Egypt G-Protein Coupled Receptor (GPCR) Targeting Market Size Growth 2021-2026 ($ millions) Figure 53. South Africa G-Protein Coupled Receptor (GPCR) Targeting Market Size Growth 2021-2026 ($ millions) Figure 54. Israel G-Protein Coupled Receptor (GPCR) Targeting Market Size Growth 2021-2026 ($ millions) Figure 55. Turkey G-Protein Coupled Receptor (GPCR) Targeting Market Size Growth 2021-2026 ($ millions) Figure 56. GCC Countries G-Protein Coupled Receptor (GPCR) Targeting Market Size Growth 2021-2026 ($ millions) Figure 57. Americas G-Protein Coupled Receptor (GPCR) Targeting Market Size 2027-2032 ($ millions) Figure 58. APAC G-Protein Coupled Receptor (GPCR) Targeting Market Size 2027-2032 ($ millions) Figure 59. Europe G-Protein Coupled Receptor (GPCR) Targeting Market Size 2027-2032 ($ millions) Figure 60. Middle East & Africa G-Protein Coupled Receptor (GPCR) Targeting Market Size 2027-2032 ($ millions) Figure 61. United States G-Protein Coupled Receptor (GPCR) Targeting Market Size 2027-2032 ($ millions) Figure 62. Canada G-Protein Coupled Receptor (GPCR) Targeting Market Size 2027-2032 ($ millions) Figure 63. Mexico G-Protein Coupled Receptor (GPCR) Targeting Market Size 2027-2032 ($ millions) Figure 64. Brazil G-Protein Coupled Receptor (GPCR) Targeting Market Size 2027-2032 ($ millions) Figure 65. China G-Protein Coupled Receptor (GPCR) Targeting Market Size 2027-2032 ($ millions) Figure 66. Japan G-Protein Coupled Receptor (GPCR) Targeting Market Size 2027-2032 ($ millions) Figure 67. Korea G-Protein Coupled Receptor (GPCR) Targeting Market Size 2027-2032 ($ millions) Figure 68. Southeast Asia G-Protein Coupled Receptor (GPCR) Targeting Market Size 2027-2032 ($ millions) Figure 69. India G-Protein Coupled Receptor (GPCR) Targeting Market Size 2027-2032 ($ millions) Figure 70. Australia G-Protein Coupled Receptor (GPCR) Targeting Market Size 2027-2032 ($ millions) Figure 71. Germany G-Protein Coupled Receptor (GPCR) Targeting Market Size 2027-2032 ($ millions) Figure 72. France G-Protein Coupled Receptor (GPCR) Targeting Market Size 2027-2032 ($ millions) Figure 73. UK G-Protein Coupled Receptor (GPCR) Targeting Market Size 2027-2032 ($ millions) Figure 74. Italy G-Protein Coupled Receptor (GPCR) Targeting Market Size 2027-2032 ($ millions) Figure 75. Russia G-Protein Coupled Receptor (GPCR) Targeting Market Size 2027-2032 ($ millions) Figure 76. Egypt G-Protein Coupled Receptor (GPCR) Targeting Market Size 2027-2032 ($ millions) Figure 77. South Africa G-Protein Coupled Receptor (GPCR) Targeting Market Size 2027-2032 ($ millions) Figure 78. Israel G-Protein Coupled Receptor (GPCR) Targeting Market Size 2027-2032 ($ millions) Figure 79. Turkey G-Protein Coupled Receptor (GPCR) Targeting Market Size 2027-2032 ($ millions) Figure 80. Global G-Protein Coupled Receptor (GPCR) Targeting Market Size Market Share Forecast by Type (2027-2032) Figure 81. Global G-Protein Coupled Receptor (GPCR) Targeting Market Size Market Share Forecast by Application (2027-2032) Figure 82. GCC Countries G-Protein Coupled Receptor (GPCR) Targeting Market Size 2027-2032 ($ millions)
Companies Mentioned
Thermo Fisher Scientific
PerkinElmer
Eurofins DiscoverX
Charles River Laboratories
Cisbio Bioassays
Promega
Abcam
Selleck Chemicals
WuXi AppTec
GenScript
Shanghai Medicilon
Merck
BD Biosciences
Molecular Devices
Qiagen
Corning
Discoverx
Methodology
LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
Data Sourse
Primary Source
Secondary Source
Players/Suppliers
Journals and Periodicals
Industry Experts
Government Bodies
Distributors/Traders
Annual Reports
Opinion Leaders
Presentations
Front-line Staff
Paid Databases
Marketing Executives
LPI Internal Repository
Data Analysis
Data Synthesis
Data Validation
Information Gathering
Triangulation with Data Models
Collation of Data
Reference Against Proprietary
Estimation of Key Figures
Databases
Analysis of Derived Insights
Corroboration with Industry Experts
Writing And Finishing Report
Qualitative Analysis
Qualitative Analysis
Market drivers
Market size and forecast
Market challenges
Market segmentation
Market trends
Geographical insights
Five forces analysis
Competitive landscape
Have A Question?
Provide comprehensive and accurate analysis and reports according to your exact requirements.
Contact Us
Select A Format
Single User License
USD3660
Multi Users License
USD5490
Corporate Users License
USD7320
Buy Now
Add To Cart
Or More Options：
PDF Download
Sample Request
Custom Request
Jump To Content
Description
Table Of Contents
List Of Tables
Companies Mentioned
Methodology
Have A Question?
Provide comprehensive and accurate analysis and reports according to your exact requirements.
Contact Us
17890 Castleton St. Suite 162 City of Industry, CA 91748 United States
Copyright © 2016-2026 LP Information All Rights Reserved
